Investigations on the cytotoxicity and antimicrobial activities of terezine E and 14-hydroxyterezine D.
Journal
Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas
ISSN: 1414-431X
Titre abrégé: Braz J Med Biol Res
Pays: Brazil
ID NLM: 8112917
Informations de publication
Date de publication:
2023
2023
Historique:
received:
19
11
2022
accepted:
01
03
2023
medline:
14
4
2023
entrez:
12
4
2023
pubmed:
13
4
2023
Statut:
epublish
Résumé
Secondary metabolites produced by endophytes are an excellent source of biologically active compounds. The newly isolated natural products terezine E and 14-hydroxyterezine D are endophytic metabolites exhibiting anticancer activity recently identified by our team (https://doi.org/10.1080/14786419.2018.1489393). In our current study, we evaluated their affinity for binding to the active site of histone deacetylase (PDB ID: 4CBT) and matrix metalloproteinase 9 (PDB ID: 4H3X) by molecular docking using AutoDock Vina software after having tested their cytotoxic activities on three cell lines (human ductal breast epithelial tumor cells (T47D)-HCC1937), human hepatocarcinoma cell line (HepG2)-HB8065), and human colorectal carcinoma cells (HCT-116)-TCP1006, purchased from ATCC, USA)). Additionally, their antimicrobial activities were investigated, and their minimum inhibitory concentration (MIC) values were determined against P. notatum and S. aureus by the broth microdilution method. Higher cytotoxicity was observed for terezine E against all tested cell lines compared to 14-hydroxyterezine D. Molecular docking results supported the high cytotoxicity of terezine E and showed higher binding affinity with 4CBT with an energy score of 9 kcal/mol. Terezine E showed higher antibacterial and antifungal activities than 14-hydroxyrerezine D: MIC values were 15.45 and 21.73 µg/mL against S. aureus and 8.61 and 11.54 µg/mL against P. notatum, respectively.
Identifiants
pubmed: 37042868
pii: S0100-879X2023000100627
doi: 10.1590/1414-431X2023e12404
pmc: PMC10085759
pii:
doi:
Substances chimiques
terezine E
0
14-hydroxyterezine D
0
Anti-Bacterial Agents
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e12404Références
Methods Mol Biol. 2015;1263:243-50
pubmed: 25618350
J Nat Prod. 2020 Mar 27;83(3):770-803
pubmed: 32162523
Bioorg Med Chem Lett. 2011 May 15;21(10):3066-9
pubmed: 21463944
BMC Cancer. 2012 Sep 03;12:386
pubmed: 22943463
J Hepatol. 2012 Jun;56(6):1343-50
pubmed: 22322234
Int J Mol Sci. 2019 Sep 04;20(18):
pubmed: 31487867
J Appl Psychol. 2010 Jul;95(4):761-8
pubmed: 20604595
Hum Reprod. 2011 Jun;26(6):1307-17
pubmed: 21427118
J Immunol Methods. 1989 May 12;119(2):203-10
pubmed: 2470825
J Comput Chem. 2010 Jan 30;31(2):455-61
pubmed: 19499576
Middle East J Dig Dis. 2010 Jan;2(1):31-41
pubmed: 25197510
Nat Prod Res. 2020 Feb;34(4):503-510
pubmed: 30092665
Clin Infect Dis. 2009 Dec 1;49(11):1749-55
pubmed: 19857164
J Cheminform. 2019 Jun 7;11(1):40
pubmed: 31175455
Onco Targets Ther. 2013 Nov 15;6:1613-24
pubmed: 24265556
Curr Opin Infect Dis. 2002 Dec;15(6):583-9
pubmed: 12821834
Intest Res. 2019 Jul;17(3):317-329
pubmed: 31085968
Arch Pharm (Weinheim). 2010 May;343(5):301-9
pubmed: 20232374
Breast Cancer Res. 2012 May 21;14(3):R79
pubmed: 22613095